Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy
GeriPal
AUGUST 4, 2022
My take home from this is that while the most preferred explanation for deprescribing statins and sedative-hypnotics is one focused on the risk of side effects, we also need to individualize it to the patient and the medication that they are taking. Welcome, Ariel. Ariel: Thanks. I’m excited to be here. Kevin: Thank you.
105 
Let's personalize your content